Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
14cc of lidocaïne®----1件: 149 💬
29060X----2件: 13, 149 💬
3Acellular nerve allograft1件: Acellular nerve allograft---1件: 149 💬
4Anakinra1件: Anakinra1件: Anakinra 💬 2件: IL1R1,
IL1R2 💬 		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬22件: 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
5Anatomical Landmark-guided Suprascapular Nerve Block----1件: 149 💬
6Baclofen1件: Baclofen1件: Baclofen 💬 2件: GABBR1,
GABBR2 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206 💬
7Behavioral: Blood flow restriction----1件: 149 💬
8Blood Flow Restriction Training (BFRT)----1件: 149 💬
9BOTOX----5件: 6, 13, 36, 149, 226 💬
10Botulinum Toxin----3件: 6, 13, 149 💬
11Botulinum toxin application----1件: 149 💬
12BOTULINUM TOXIN TYPE A1件: Botulinum toxin type A4件: Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬13件: 2, 5, 6, 7, 13, 15, 17, 47, 70, 113, 149, 171, 226 💬
13Botulinum toxin type A (Botox®, Allergan)1件: Botulinum toxin type A4件: Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 149 💬
14Brivaracetam1件: Brivaracetam1件: Brivaracetam 💬 1件: SV2A 💬 1件: ECM-receptor interaction 💬2件: 149, 309 💬
15Diagnostic Test: gait analysis----1件: 149 💬
16Diagnostic Test: Nociceptor flexor reflex----1件: 149 💬
17Edonerpic1件: Edonerpic---1件: 149 💬
18Ezetimibe1件: Ezetimibe1件: Ezetimibe 💬 1件: NPC1L1 💬 1件: Fat digestion and absorption 💬5件: 49, 79, 93, 149, 260 💬
19FENFLURAMINE1件: Fenfluramine2件: Fenfluramine hydrochloride ,
Fenfluramine 💬 		5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬 		11件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬6件: 140, 143, 144, 145, 149, 156 💬
20Genetic: whole exome sequencing----6件: 2, 6, 65, 120, 127, 149 💬
21HC-58----1件: 149 💬
22Lacosamide1件: Lacosamide1件: Lacosamide 💬 2件: SCN3A,
SCN9A 💬 		1件: Taste transduction 💬4件: 2, 46, 149, 298 💬
23Levetiracetam1件: Levetiracetam1件: Levetiracetam 💬 1件: SV2A 💬 1件: ECM-receptor interaction 💬7件: 2, 4, 6, 13, 34, 149, 307 💬
24Medicinal air----1件: 149 💬
25Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬18件: 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
26MEOPA----1件: 149 💬
27Mirror Therapy----1件: 149 💬
28Onabotulinumtoxina for Injection----1件: 149 💬
29Other: Balance exercise----2件: 6, 149 💬
30Other: Berg Balance Scale----3件: 6, 13, 149 💬
31Other: Blood flow restriction training----3件: 6, 149, 274 💬
32Other: Child Sensory Profile 2 (SP2) for Sensory processing abilities----1件: 149 💬
33Other: Conservative rehabilitation----1件: 149 💬
34Other: Conventional Rehabilitation----1件: 149 💬
35Other: Exergaming----1件: 149 💬
36Other: HUMAC Balance System for Postural stability evaluation----1件: 149 💬
37Other: Measurement of multifidus and gastrocnemius muscle thickness with Ultrasound----1件: 149 💬
38Other: Reactive Balance Training----1件: 149 💬
39Other: Review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry.1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 149 💬
40Other: Selective Motor Control Evaluation for the upper and lower extremities----1件: 149 💬
41Other: Standard medical treatment----6件: 13, 96, 97, 149, 153, 171 💬
42Other: The patients' parents have to complete the VINELAND II adaptive behavior scales scoring, The Sleep Disturbance Scale for Children (SDSC) and Horne & Ostberg Circadian Typology Questionnaire----1件: 149 💬
43Other: the selected physical therapy program----1件: 149 💬
44Oxygen1件: Oxygen1件: Oxygen 💬 --30件: 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
45Padsevonil1件: Padsevonil1件: Padsevonil 💬 3件: SV2A,
SV2B,
SV2C 💬 		1件: ECM-receptor interaction 💬1件: 149 💬
46Psilocybin1件: Psilocybin1件: Psilocybin 💬 1件: HTR2A 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬5件: 2, 6, 13, 149, 206 💬
47Psilocybin (Usona Institute)1件: Psilocybin1件: Psilocybin 💬 1件: HTR2A 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 149 💬
48Repetitive Transcranial Magnetic Stimulation (rTMS)----1件: 149 💬
49Sham Mirror Therapy----1件: 149 💬
50Sodium Oxybate1件: Sodium oxybate1件: Sodium oxybate 💬 --2件: 6, 149 💬
51Time delay treatment of botulinum toxin----1件: 149 💬
52Tocilizumab1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬26件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
53Triheptanoin1件: Triheptanoin1件: Triheptanoin 💬 --12件: 2, 8, 65, 149, 156, 248, 256, 257, 317, 318, 324, 344 💬
54Ultrasound-guided Suprascapular Nerve Block----1件: 149 💬
55Upper limb muscle block----1件: 149 💬
56Virtual Balance Training----1件: 149 💬
57Virtual reality----1件: 149 💬